Downstaging disease in patients with hepatocellular carcinoma outside of milan criteria: Strategies using drug-eluting bead chemoembolization

Journal of Vascular and Interventional Radiology

Volumn 24, Issue 11, 2013, Pages 1613-1622

  Green, Tyler J ^a   Rochon, Paul J ^a   Chang, Samuel ^a   Ray, Charles E ^a   Winston, Helena ^b   Ruef, Robert ^d   Kreidler, Sarah M ^c   Glueck, Deborah H ^c   Shulman, Benjamin C ^c   Brown, Anthony C ^a   Durham, Janette ^a  

^a UNIVERSITY OF COLORADO HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BILIRUBIN; DOXORUBICIN;

ADULT; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD PUGH SCORE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG ELUTING BEAD; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MODEL FOR END STAGE LIVER DISEASE SCORE; MULTIPLE CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; TUMOR VOLUME;

AFP; CI; CONFIDENCE INTERVAL; DEB; DOXORUBICIN-ELUTING BEAD; EASTERN COOPERATIVE ONCOLOGY GROUP; ECOG; HCC; HEPATOCELLULAR CARCINOMA; MODIFIED RESPONSE EVALUATION CRITERIA IN SOLID TUMORS; MRECIST; UCSF; UNITED NETWORK FOR ORGAN SHARING; UNIVERSITY OF CALIFORNIA, SAN FRANCISCO; UNOS; Α- FETOPROTEIN;

AGED; ALPHA-FETOPROTEINS; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; CHEMOTHERAPY, ADJUVANT; COLORADO; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84886950845     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2013.07.024     Document Type: Article

References (23)

1. B. Nemes, F. Gelley, and L. Piros The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program Transplant Proc 43 2011 1272 1274
2. J. Lei, W. Wang, and L. Yan Downstaging advanced hepatocellular carcinoma to the Milan criteria may provide a comparable outcome to conventional Milan criteria J Gastrointest Surg 17 2013 1440 1446
3. V. Mazzaferro, E. Regalia, and R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
4. F.Y. Yao, R.K. Kerlan Jr, and R. Hirose Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis Hepatology 48 2008 819 827
5. M. Ravaioli, G.L. Grazi, and F. Piscaglia Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria Am J Transplant 8 2008 2547 2557
6. R.J. Lewandowski, L.M. Kulik, and A. Riaz A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization Am J Transplant 9 2009 1920 1928
7. A.N. Gordon-Weeks, A. Snaith, T. Petrinic, P.J. Friend, A. Burls, and M.A. Silva Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria Br J Surg 98 2011 1201 1208
8. P.E. Majno, R. Adam, and H. Bismuth Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis Ann Surg 226 1997 688 701
9. C.U. Yu, T.L. Ou, and T.Y. Huang Hepatocellular carcinoma downstaging in liver transplantation Transplant Proc 44 2012 412 414
10. F.Y. Yao, R. Hirose, and J. LaBerge A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation Liver Transpl 11 2005 1505 1514
11. J. Bruix, and M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
12. Organ Procurement and Transplantation Network. Policy 3.6: Allocation of Livers. Available at: http://optn.transplant.hrsa.gov/PoliciesandBylaws2/ policies/pdfs/policy-8.pdf. Accessed March 10, 2013.
13. EASL-EORTC Clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 2012; 56:908-943.
14. R. Lencioni, and J.M. Llovet Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis 30 2010 52 60
15. F.Y. Yao, L. Ferrell, and N.M. Bass Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Hepatology 33 2001 1394 1403
16. K.F. Hirji, C.R. Mehta, and N.R. Patel Computing distributions for exact logistic regression J Am Stat Assoc 82 1987 1110 1117
17. C. Toso, G. Mentha, N.M. Kneteman, and P. Majno The place of downstaging for hepatocellular carcinoma J Hepatol 52 2010 930 936
18. W.C. Chapman, M.B. Majella Doyle, and J.E. Stuart Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation Ann Surg 248 2008 617 625
19. J.W. Jang, C.R. You, and C.W. Kim Benefit of downsizing hepatocellular carcinoma in a liver transplant population Aliment Pharmacol Ther 31 2010 415 423
20. V. Bova, R. Miraglia, L. Maruzzelli, G.B. Vizzini, and A. Luca Predictive factors of downstaging of hepatocellular carcinoma beyond the Milan criteria treated with intra-arterial therapies Cardiovasc Interv Radiol 36 2013 433 439
21. Y.S. Kim, H.K. Lim, and H. Rhim Recurrence of hepatocellular carcinoma after liver transplantation: patterns and prognostic factors based on clinical and radiologic features AJR Am J Roentgenol 189 2007 (352-258)
22. A.R. Hakeem, R.S. Young, and J.P. Marangoni Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma Aliment Pharmacol Ther 35 2012 987 999
23. G. Otto, S. Herber, and M. Heise Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma Liver Transpl 12 2006 1260 1267